Forums
New posts
Search forums
What's new
New posts
New media
New media comments
Latest activity
Classifieds
Media
New media
New comments
Search media
Log in
Register
What's New?
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More Options
Advertise with us
Contact Us
Close Menu
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Forums
The Water Cooler
General Discussion
Why Is Media Suppressing Info About Hydroxychloroquine's Effectiveness?
Search titles only
By:
Reply to Thread
This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.
Message
<blockquote data-quote="_CY_" data-source="post: 3408892" data-attributes="member: 7629"><p>thank you .. thank you, thank you for weighting in!</p><p>here's the actual study for HCQ effectiveness with and without zinc. </p><p></p><p>-----------</p><p></p><p>Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and </p><p>azithromycin alone: outcomes in hospitalized COVID-19 patients </p><p><a href="https://www.researchgate.net/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients" target="_blank">https://www.researchgate.net/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients</a></p><p></p><p>pdf link: <a href="https://www.researchgate.net/profile/Philip_Carlucci/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients/links/5eb5a9a292851cd50da38727/Hydroxychloroquine-and-azithromycin-plus-zinc-vs-hydroxychloroquine-and-azithromycin-alone-outcomes-in-hospitalized-COVID-19-patients.pdf" target="_blank">https://www.researchgate.net/profile/Philip_Carlucci/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients/links/5eb5a9a292851cd50da38727/Hydroxychloroquine-and-azithromycin-plus-zinc-vs-hydroxychloroquine-and-azithromycin-alone-outcomes-in-hospitalized-COVID-19-patients.pdf</a></p><p></p><p>Abstract</p><p>Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection. As a result of in vitro evidence suggesting zinc sulfate may be efficacious against COVID-19, our hospitals began using zinc sulfate as add-on therapy to hydroxychloroquine and azithromycin. We performed a retrospective observational study to compare hospital outcomes among patients who received hydroxychloroquine and azithromycin plus zinc versus hydroxychloroquine and azithromycin alone. Methods: Data was collected from electronic medical records for all patients being treated with admission dates ranging from March 2, 2020 through April 5, 2020. Initial clinical characteristics on presentation, medications given during the hospitalization, and hospital outcomes were recorded. Patients in the study were excluded if they were treated with other investigational medications. Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.</p></blockquote><p></p>
[QUOTE="_CY_, post: 3408892, member: 7629"] thank you .. thank you, thank you for weighting in! here's the actual study for HCQ effectiveness with and without zinc. ----------- Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients [URL]https://www.researchgate.net/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients[/URL] pdf link: [URL]https://www.researchgate.net/profile/Philip_Carlucci/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients/links/5eb5a9a292851cd50da38727/Hydroxychloroquine-and-azithromycin-plus-zinc-vs-hydroxychloroquine-and-azithromycin-alone-outcomes-in-hospitalized-COVID-19-patients.pdf[/URL] Abstract Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection. As a result of in vitro evidence suggesting zinc sulfate may be efficacious against COVID-19, our hospitals began using zinc sulfate as add-on therapy to hydroxychloroquine and azithromycin. We performed a retrospective observational study to compare hospital outcomes among patients who received hydroxychloroquine and azithromycin plus zinc versus hydroxychloroquine and azithromycin alone. Methods: Data was collected from electronic medical records for all patients being treated with admission dates ranging from March 2, 2020 through April 5, 2020. Initial clinical characteristics on presentation, medications given during the hospitalization, and hospital outcomes were recorded. Patients in the study were excluded if they were treated with other investigational medications. Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19. [/QUOTE]
Insert Quotes…
Verification
Post Reply
Forums
The Water Cooler
General Discussion
Why Is Media Suppressing Info About Hydroxychloroquine's Effectiveness?
Search titles only
By:
Top
Bottom